
News|Videos|September 12, 2025
David Brousseau, MD: Benefits of timely opioid dosing for SCD pain
Author(s)David Brousseau, MD, MS
Fact checked by: Joshua Fitch, Senior Editor
Study author David Brousseau, MD, MS, explains the benefit of a child being able to go home after a sickle cell disease-associated ED visit.
Advertisement
Advertisement
Children with sickle cell disease (SCD) experiencing acute pain episodes may avoid hospitalization when opioids are administered promptly in the emergency department (ED), according to a recent multisite study
Related to this article

Suicide-related pediatric ED visits rose 74% from 2016 to 2022; about half occurred at EDs with lower pediatric volume, a national analysis found.

A recap of the top FDA approvals, authorizations, and regulatory decisions affecting pediatric care during August 2026.

Nine societies outline 6 domains of hospital-level sepsis strategies, from rapid blood culture diagnostics to daily toothbrushing protocols.

Jonathan Miller, MD, discusses earlier HPV vaccination, individualized conversations with hesitant families, and strategies to improve vaccine uptake.

Jonathan Miller, MD, discusses factors behind lagging HPV vaccination rates and how pediatricians can address common parent concerns.

In a Hirschsprung disease mouse model, diet shifted gut microbes and inflammation, with a 3-fold survival difference between standard diets.

The latest IDSA histoplasmosis update adds a consensus statement on severe disease and outlines when children with pulmonary infection warrant itraconazole therapy.
Advertisement
Advertisement

